These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 8229230)
1. Clinical evaluation of interictal fluorine-18-fluorodeoxyglucose PET in partial epilepsy. Henry TR; Engel J; Mazziotta JC J Nucl Med; 1993 Nov; 34(11):1892-8. PubMed ID: 8229230 [TBL] [Abstract][Full Text] [Related]
2. Interictal cerebral metabolism in partial epilepsies of neocortical origin. Henry TR; Sutherling WW; Engel J; Risinger MW; Levesque MF; Mazziotta JC; Phelps ME Epilepsy Res; 1991; 10(2-3):174-82. PubMed ID: 1817957 [TBL] [Abstract][Full Text] [Related]
3. Double-blind stereo-EEG and FDG PET study in severe partial epilepsies: are the electric and metabolic findings related? Lucignani G; Tassi L; Fazio F; Galli L; Grana C; Del Sole A; Hoffman D; Francione S; Minicucci F; Kahane P; Messa C; Munari C Eur J Nucl Med; 1996 Nov; 23(11):1498-507. PubMed ID: 8854849 [TBL] [Abstract][Full Text] [Related]
4. The prognostic value of [F]FDG-PET in nonrefractory partial epilepsy. Weitemeyer L; Kellinghaus C; Weckesser M; Matheja P; Loddenkemper T; Schuierer G; Schober O; Ringelstein EB; Lüdemann P Epilepsia; 2005 Oct; 46(10):1654-60. PubMed ID: 16190939 [TBL] [Abstract][Full Text] [Related]
5. Diagnostic performance of [18F]FDG-PET and ictal [99mTc]-HMPAO SPECT in occipital lobe epilepsy. Kim SK; Lee DS; Lee SK; Kim YK; Kang KW; Chung CK; Chung JK; Lee MC Epilepsia; 2001 Dec; 42(12):1531-40. PubMed ID: 11879363 [TBL] [Abstract][Full Text] [Related]
6. Positron emission tomography studies of cerebral glucose metabolism in chronic partial epilepsy. Abou-Khalil BW; Siegel GJ; Sackellares JC; Gilman S; Hichwa R; Marshall R Ann Neurol; 1987 Oct; 22(4):480-6. PubMed ID: 3124709 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic Performance of Positron Emission Tomography for the Presurgical Evaluation of Patients with Non-lesional Intractable Partial Epilepsy: Comparison among 18F-FDG, 11C-Flumazenil, and 11C-Flumazenil Binding Potential Imaging Using Statistical Imaging Analysis. Komoto D; Iida K; Higaki T; Kaichi Y; Takauchi K; Arihiro K; Kakita A; Hirokawa Y; Awai K Hiroshima J Med Sci; 2015 Dec; 64(4):51-7. PubMed ID: 26964154 [TBL] [Abstract][Full Text] [Related]
8. FDG-PET and volumetric MRI in the evaluation of patients with partial epilepsy. Gaillard WD; Bhatia S; Bookheimer SY; Fazilat S; Sato S; Theodore WH Neurology; 1995 Jan; 45(1):123-6. PubMed ID: 7824101 [TBL] [Abstract][Full Text] [Related]
9. The role of fluorodeoxyglucose-positron emission tomography in the evaluation of seizure disorders. Theodore WH Semin Neurol; 1989 Dec; 9(4):301-6. PubMed ID: 2518339 [No Abstract] [Full Text] [Related]
10. The role of positron emission tomography with [18F]fluorodeoxyglucose in the evaluation of the epilepsies. Henry TR; Votaw JR Neuroimaging Clin N Am; 2004 Aug; 14(3):517-35, ix. PubMed ID: 15324862 [TBL] [Abstract][Full Text] [Related]
11. Presurgical evaluation for partial epilepsy: relative contributions of chronic depth-electrode recordings versus FDG-PET and scalp-sphenoidal ictal EEG. Engel J; Henry TR; Risinger MW; Mazziotta JC; Sutherling WW; Levesque MF; Phelps ME Neurology; 1990 Nov; 40(11):1670-7. PubMed ID: 2122275 [TBL] [Abstract][Full Text] [Related]
12. 18F-labeled 2-deoxy-2-fluoro-D-glucose positron-emission tomography scans for the localization of the epileptogenic foci. Hotta SS Health Technol Assess (Rockv); 1998 Jul; (12):i-vi, 1-17. PubMed ID: 9803323 [TBL] [Abstract][Full Text] [Related]
13. Brain molecular imaging in pharmacoresistant focal epilepsy: Current practice and perspectives. Verger A; Lagarde S; Maillard L; Bartolomei F; Guedj E Rev Neurol (Paris); 2018; 174(1-2):16-27. PubMed ID: 28595975 [TBL] [Abstract][Full Text] [Related]
14. FDG-positron emission tomography and invasive EEG: seizure focus detection and surgical outcome. Theodore WH; Sato S; Kufta CV; Gaillard WD; Kelley K Epilepsia; 1997 Jan; 38(1):81-6. PubMed ID: 9024188 [TBL] [Abstract][Full Text] [Related]
15. [18F]fluorodeoxyglucose positron emission tomography in refractory complex partial seizures. Theodore WH; Newmark ME; Sato S; Brooks R; Patronas N; De La Paz R; DiChiro G; Kessler RM; Margolin R; Manning RG Ann Neurol; 1983 Oct; 14(4):429-37. PubMed ID: 6416141 [TBL] [Abstract][Full Text] [Related]
16. The utility of 18F-fluorodeoxyglucose PET (FDG PET) in epilepsy surgery. Rathore C; Dickson JC; Teotónio R; Ell P; Duncan JS Epilepsy Res; 2014 Oct; 108(8):1306-14. PubMed ID: 25043753 [TBL] [Abstract][Full Text] [Related]
17. Relationship between preoperative hypometabolism and surgical outcome in neocortical epilepsy surgery. Wong CH; Bleasel A; Wen L; Eberl S; Byth K; Fulham M; Somerville E; Mohamed A Epilepsia; 2012 Aug; 53(8):1333-40. PubMed ID: 22709127 [TBL] [Abstract][Full Text] [Related]
18. Drug-induced changes in cerebral glucose consumption in bifrontal epilepsy. Matheja P; Weckesser M; Debus O; Löttgen J; Schuierer G; Schober O; Kurlemann G Epilepsia; 2000 May; 41(5):588-93. PubMed ID: 10802765 [TBL] [Abstract][Full Text] [Related]
19. Is central benzodiazepine receptor imaging useful for the identification of epileptogenic foci in localization-related epilepsies? Goethals I; Van de Wiele C; Boon P; Dierckx R Eur J Nucl Med Mol Imaging; 2003 Feb; 30(2):325-8. PubMed ID: 12552355 [TBL] [Abstract][Full Text] [Related]
20. Positron emission tomography in partial epilepsies: the clinical point of view. Koutroumanidis M; Binnie CD; Panayiotopoulos CP Nucl Med Commun; 1998 Dec; 19(12):1123-6. PubMed ID: 9885801 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]